Literature DB >> 24503994

Draft Genome and Plasmid Sequences of Chlamydia pneumoniae Strain B21 from an Australian Endangered Marsupial, the Western Barred Bandicoot.

Eileen Roulis1, Nathan Bachmann, Adam Polkinghorne, Margaret Hammerschlag, Stephan Kohlhoff, Peter Timms.   

Abstract

Chlamydia pneumoniae is a ubiquitous intracellular pathogen, first associated with human respiratory disease and subsequently detected in a range of mammals, amphibians, and reptiles. Here we report the draft genome sequence for strain B21 of C. pneumoniae, isolated from the endangered Australian marsupial the western barred bandicoot.

Entities:  

Year:  2014        PMID: 24503994      PMCID: PMC3916488          DOI: 10.1128/genomeA.01223-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Chlamydia pneumoniae is an obligate intracellular bacterium associated with community-acquired pneumonia and detected in cold- and warm-blooded hosts such as amphibians, reptiles, marsupials, and humans (1–3). Although minor genetic differences suggest that human strains are a result of several zoonotic events in this pathogen’s history, both human and koala strains of C. pneumoniae are highly conserved in their gene content and organization (4). Interestingly, a previous study examining selected molecular targets in marsupial C. pneumoniae isolates demonstrated identical sequences for all isolates tested (5). With this in mind, we sequenced the chromosome and plasmid of B21, an isolate from the western barred bandicoot (Perameles bougainville), an endangered Western Australian marsupial. The C. pneumoniae B21 chromosome and plasmid were sequenced in duplicate using the Ion Torrent platform P1 chip with 200-bp chemistry, resulting in over 120 million reads. Read quality analyses were performed using FASTQC version 0.10.1 (Babraham Bioinformatics group [http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc]), with average Phred scores of 24. CLC Genomics Workbench (version 6.0.2; CLC bio, Denmark) was used to trim sequences as well as perform de novo assembly and readmapping, with read coverages exceeding 5,000×. The de novo assembly consists of 164 chromosomal contig sequences and a single contig for the plasmid. The predicted length of the C. pneumoniae B21 chromosome is 1,241,009 bp, with GC content of 40.5%. The B21 plasmid is 7,529 nucleotides (nt) in length, with a GC content of 33.0%. Automatic annotation was performed using RAST (6) and manually curated using Artemis (7). The draft B21 chromosome and plasmid were pairwise aligned to all available C. pneumoniae genome and plasmid sequences (4, 8–11) by use of Multiple Alignment using Fast Fourier Transform (MAFFT) (12). The B21 chromosome contains 1,308 predicted coding sequences (CDS) with 37 tRNAs and a single rRNA operon, while the B21 plasmid has eight predicted CDS. Nucleotide variants were predicted by mapping the reads of C. pneumoniae B21 to the complete genome of C. pneumoniae LPCoLN, a koala strain. Twenty-six variants were predicted, of which 15 are within homopolymeric tracts of various lengths. Four variants are predicted within intergenic regions. PCR and sequencing analysis of four variants has demonstrated identical sequences to those of LPCoLN. The B21 chromosome is 99.99% identical to that of LPCoLN and 96.9% identical to human strains. Two open reading frames (ORFs) are predicted for the pmp18 (pmpE/F) B21 homolog, which are full length in human strains and a pseudogene in LPCoLN. The B21 plasmid has 99.99% nucleotide identity to the LPCoLN plasmid and 96.3% identity to the horse C. pneumoniae N16 plasmid isolate (13). A single nucleotide deletion is noted at the 3′ end of locus X556p_1186 in the B21 plasmid within a homopolymeric tract, resulting in the truncation of X556p_1186 in B21 by 8 amino acids. X556p_1186 is predicted to encode pGP3-D, a putative virulence factor associated with growth of Chlamydia in mammalian cells (14).

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number AZNB00000000. The version described in this paper is version AZNB01000000.
  14 in total

1.  Artemis: sequence visualization and annotation.

Authors:  K Rutherford; J Parkhill; J Crook; T Horsnell; P Rice; M A Rajandream; B Barrell
Journal:  Bioinformatics       Date:  2000-10       Impact factor: 6.937

2.  MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform.

Authors:  Kazutaka Katoh; Kazuharu Misawa; Kei-ichi Kuma; Takashi Miyata
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

3.  Plasmid diversity in Chlamydia.

Authors:  N S Thomas; M Lusher; C C Storey; I N Clarke
Journal:  Microbiology (Reading)       Date:  1997-06       Impact factor: 2.777

4.  Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

Authors:  T D Read; R C Brunham; C Shen; S R Gill; J F Heidelberg; O White; E K Hickey; J Peterson; T Utterback; K Berry; S Bass; K Linher; J Weidman; H Khouri; B Craven; C Bowman; R Dodson; M Gwinn; W Nelson; R DeBoy; J Kolonay; G McClarty; S L Salzberg; J Eisen; C M Fraser
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

5.  Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA.

Authors:  M Shirai; H Hirakawa; M Kimoto; M Tabuchi; F Kishi; K Ouchi; T Shiba; K Ishii; M Hattori; S Kuhara; T Nakazawa
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

6.  Comparative genomes of Chlamydia pneumoniae and C. trachomatis.

Authors:  S Kalman; W Mitchell; R Marathe; C Lammel; J Fan; R W Hyman; L Olinger; J Grimwood; R W Davis; R S Stephens
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

7.  The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents.

Authors:  Mark A Pickett; J Sylvia Everson; Patrick J Pead; Ian N Clarke
Journal:  Microbiology (Reading)       Date:  2005-03       Impact factor: 2.777

8.  Chlamydia pneumoniae is genetically diverse in animals and appears to have crossed the host barrier to humans on (at least) two occasions.

Authors:  Candice M Mitchell; Susan Hutton; Garry S A Myers; Robert Brunham; Peter Timms
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

Review 9.  Chlamydia pneumoniae: modern insights into an ancient pathogen.

Authors:  Eileen Roulis; Adam Polkinghorne; Peter Timms
Journal:  Trends Microbiol       Date:  2012-12-05       Impact factor: 17.079

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  3 in total

Review 1.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

2.  Phylogenetic analysis of human Chlamydia pneumoniae strains reveals a distinct Australian indigenous clade that predates European exploration of the continent.

Authors:  Eileen Roulis; Nathan Bachmann; Michael Humphrys; Garry Myers; Wilhelmina Huston; Adam Polkinghorne; Peter Timms
Journal:  BMC Genomics       Date:  2015-12-22       Impact factor: 3.969

3.  The Genetic Transformation of Chlamydia pneumoniae.

Authors:  Ian N Clarke; Jan Rupp; Kensuke Shima; Maximilian Wanker; Rachel J Skilton; Lesley T Cutcliffe; Christiane Schnee; Thomas A Kohl; Stefan Niemann; Javier Geijo; Matthias Klinger; Peter Timms; Thomas Rattei; Konrad Sachse
Journal:  mSphere       Date:  2018-10-10       Impact factor: 4.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.